Known targets — ChEMBL curated mechanism
SLC6A2SLC6A3SSTR1SSTR2SSTR3SSTR5
The experimentally established mechanism targets of Aspartic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CPT2 | P23786 | 1/20 | 0.41 |
| ▸ | CPT1A | P50416 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LDHA | P00338 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aspartic Acid SCHEMBL28885522 | 1.00 | CA4 (0.50) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL26678179 | 1.00 | CA4 (0.50) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL120390 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL30114648 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL381741 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL2117573 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL120392 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL21054602 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL22401093 | 0.97 | CA4 (0.52) | CA4CA2CTSLCPT2CPT1A | |
| Aspartic Acid SCHEMBL23322527 | 0.95 | CA4 (0.46) | CA4CA2CTSLCPT2CPT1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114373870-B | Method for improving electron transmission efficiency of tin dioxide-lead halide perovskite interface | 中国科学院金属研究所 | 2025-02-25 | — | — | CN | claimed |
| CN-114373870-A | Method for improving electron transmission efficiency of tin dioxide-halogenated lead perovskite interface | 中国科学院金属研究所 | 2022-04-19 | — | — | CN | claimed |
| CN-111517970-A | Preparation method of L-aspartic acid sodium salt monohydrate | 安徽安力肽生物科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| US-4035513-A | COSMETICS | SHISEIDO CO., LTD. (JA) | 1977-07-12 | — | — | US | claimed |
| EP-4744509-A1 | TASTE COMPOSITION FOR ENHANCING SALTY TASTE AND SALT-REDUCED SEASONING AND SALT-REDUCED FOODS OR BEVERAGES PRODUCED USING THE SAME | The University of Tokyo (JP) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025230736-A1 | ENGINEERED BIOCATALYSTS FOR THE SYNTHESIS OF GAMMA-HYDROXY AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-11-06 | — | — | WO | disclosed |
| US-20250325591-A1 | THERAPY FOR HEPATIC DISORDERS USING ADIPOSE-DERIVED MESENCHYMAL STEM CELL LINE | UNIV KEIO (JP) | 2025-10-23 | — | — | US | disclosed |
| US-12383476-B2 | W/O/W emulsion composition | SHISEIDO COMPANY, LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| US-20250223619-A1 | ENGINEERED BIOCATALYSTS FOR THE SYNTHESIS OF GAMMA-HYDROXY AMINO ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-07-10 | — | — | US | disclosed |
| US-20250146070-A1 | METHOD FOR DETERMINING WHETHER ASC IS INCLUDED AT HIGH PURITY IN ADIPOSE TISSUE-DERIVED CELL POPULATION | KEIO UNIVERSITY (JP) | 2025-05-08 | — | — | US | disclosed |
| US-12281341-B2 | Engineered biocatalysts for the synthesis of gamma-hydroxy amino acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-04-22 | — | — | US | disclosed |
| CN-114373870-B | Method for improving electron transmission efficiency of tin dioxide-lead halide perovskite interface | 中国科学院金属研究所 | 2025-02-25 | — | — | CN | disclosed |
| US-20020045027-A1 | Anti-fog resin sheet, anti-fog agent and method article | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-04-18 | — | — | US | disclosed |
| EP-1184408-A2 | Anti-fog resin sheet, anti-fog agent and molded article | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-03-06 | — | — | EP | disclosed |
| EP-0612530-B1 | Pharmaceutical preparations containing tumor cytotoxic factor | SNOW BRAND MILK PRODUCTS CO LTD (JP) | 2000-11-08 | — | — | EP | disclosed |
| US-5814321-A | EMULSIFIER NONIONIC SURFACTANTS POLYHYDRIC ALCOHOLS WITH ESTERS, GLYCERIDES AND POLYOXYALKYLENE GLYCOL ESTERS AND ANTIGENS | JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE (JP) | 1998-09-29 | — | — | US | disclosed |
| EP-0781559-A2 | Oil adjuvant vaccine and method for preparing same | Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute (JP) | 1997-07-02 | — | — | EP | disclosed |
| EP-0152275-B1 | PRODUCTION OF AMINO ACIDS VIA BIOCONVERSION | THE NUTRASWEET COMPANY (a Delaware corporation) (US) | 1991-06-19 | — | — | EP | disclosed |
| EP-0152275-A2 | Production of amino acids via bioconversion | THE NUTRASWEET COMPANY (a Delaware corporation) (US) | 1985-08-21 | — | — | EP | disclosed |
| US-4035513-A | COSMETICS | SHISEIDO CO., LTD. (JA) | 1977-07-12 | — | — | US | disclosed |